Oct 15, 2016 Issue
Fever and Rash in a Patient with HIV Infection [Photo Quiz]

A man with HIV presented with fever and widespread, severely painful, pruritic vesicles and pustules.

Sep 1, 2016 Issue
CDC Releases Updated Guidelines for Postexposure Prophylaxis After Sexual, Injection Drug, or Other Nonoccupational Exposures to HIV [Practice Guidelines]

Postexposure prophylaxis (PEP) with anti-retroviral drugs to prevent transmission of human immunodeficiency virus (HIV) following sexual or injection drug use exposures (nonoccupational PEP or nPEP) is an essential intervention requiring a timely response. Updated guidelines from the Centers for Dis...

Mar 15, 2016 Issue
Preexposure Prophylaxis with Tenofovir/Emtricitabine Prevents HIV Infection in Men Who Have Unprotected Anal Intercourse [POEMs]

Preexposure prophylaxis in high-risk men who have unprotected anal intercourse reduces the likelihood of developing HIV (number needed to treat = 17 per year). Participants averaged 15 pills per month, which costs approximately $700 per month ($8,400 per year). Condoms would be a much more cost-effe...

Apr 1, 2015 Issue
HIV Prevention: Recommendations from the International Antiviral Society—USA Panel [Practice Guidelines]

With the introduction of combination antiretroviral therapy (ART), human immunodeficiency virus (HIV) has become a chronic disease that can be managed, rather than a deadly infection. The International Antiviral Society—USA Panel has provided recommendations regarding these approaches that, when app...

Mar 15, 2015 Issue
ART for HIV: Recommendations from the International Antiviral Society—USA Panel [Practice Guidelines]

The International Antiviral Society—USA Panel has provided recommendations for management of HIV infection with antiretroviral therapy (ART). Evidence has shown that ART for treatment of human immunodeficiency virus (HIV) infection is effective in preventing transmission among couples. Additionally,...

Apr 15, 2014 Issue
Screening for HIV: Recommendation Statement [U.S. Preventive Services Task Force]

The U.S. Preventive Services Task Force (USPSTF) recommends that clinicians screen for human immunodeficiency virus (HIV) infection in adolescents and adults 15 to 65 years of age. Younger adolescents and older adults who are at increased risk should also be screened.

Apr 15, 2014 Issue
Screening for HIV [Putting Prevention into Practice]

A 19-year-old woman presents to the university health clinic for a well-woman examination. She reports no problems and mentions that she is sexually active with one male partner, who usually uses condoms. She has never been screened for a sexually transmitted infection.

Apr 15, 2014 Issue
AAFP Recommends Universal Screening for HIV Infection Beginning at 18 Years of Age [Editorials]

The AAFP recommends delaying the start of routine HIV screening until 18 years of age, and screening all patients 18 to 65 years of age. The AAFP notes that screening younger patients may still be beneficial based on high-risk behaviors.

Feb 15, 2014 Issue
What Is New in HIV Infection? [Article]

Human immunodeficiency virus (HIV) prevention and treatment updates include screening recommendations, fourth-generation testing, preexposure prophylaxis, and a paradigm shift; treatment is prevention. The U.S. Preventive Services Task Force recommends routine HIV screening in persons 15 to 65 years...

Oct 15, 2013 Issue
Emtricitabine/Tenofovir (Truvada) for HIV Prophylaxis [STEPS]

When used with a comprehensive HIV prevention strategy, emtricitabine/tenofovir effectively prevents HIV-1 infection in high-risk patients. Adherence to daily dosing is important to maintain protection. The cost of therapy may limit access, and not all insurance companies currently cover its use for HIV prophylaxis.

Pages: Previous 1 2 3 4 5 6 7 Next

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now